Pfizer to discontinue twice-daily weight reduction tablet because of excessive charges of difficult uncomfortable side effects
Pfizer stated it could prevent creating the twice-daily model of its experimental weight reduction tablet after overweight sufferers taking the drug misplaced weight however had bother tolerating the drug in a mid-stage